# ScoreItem: Fraturas

**ID:** `019bf31d-2ef0-7a31-b8c9-0f54b201dbcb`
**FullName:** Fraturas (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Segmentos apendiculares)

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 16 artigos
- Avg Similarity: 0.559

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7a31-b8c9-0f54b201dbcb`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7a31-b8c9-0f54b201dbcb",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Fraturas (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Segmentos apendiculares)

**30 chunks de 16 artigos (avg similarity: 0.559)**

### Chunk 1/30
**Article:** Fragility Fractures and the Osteoporosis Care Gap in Women: The OSIRIS Study (2013)
**Journal:** Journal of Bone and Mineral Research
**Section:** abstract | **Similarity:** 0.641

This study documented the care gap in fragility fracture management, finding that fewer than 20% of patients with fragility fractures receive appropriate osteoporosis investigation and treatment. Fragility fractures indicate underlying bone fragility and substantially increase risk of subsequent fractures. The study emphasizes the critical need for systematic post-fracture assessment including bone densitometry and initiation of anti-osteoporotic therapy to prevent future fractures.

---

### Chunk 2/30
**Article:** FRAX and the assessment of fracture probability in men and women from the UK (2008)
**Journal:** Osteoporosis International
**Section:** abstract | **Similarity:** 0.630

Development and validation of FRAX algorithm integrating BMD T-scores with clinical risk factors for fracture probability assessment. Demonstrates superior fracture prediction when combining T-score with age, prior fractures, family history, and other risk factors. Establishes intervention thresholds based on 10-year fracture probability.

---

### Chunk 3/30
**Article:** Terapia de Reposi√ß√£o Hormonal Feminina II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.608

; divulga√ß√£o em 2002; seguimento planejado de 7‚Äì10 anos e acompanhamento de 13 anos.
- Amostra total >16.000; ~50% em terapia hormonal; crit√©rios de exclus√£o relacionados a fogachos responderam por ~90%.
- Participantes entre 50‚Äì79 anos; m√©dia de idade 63 anos; em m√©dia 12 anos p√≥s-menopausa ao iniciar tratamento, reduzindo a aplicabilidade √† janela precoce.
- Premarin cont√©m 10 tipos de estrog√™nio, apenas 3 an√°logos ao humano; medroxiprogesterona tem pot√™ncia ~3 vezes maior no receptor de progesterona, fatores que podem influenciar efeitos e seguran√ßa.
- Valor de refer√™ncia de signific√¢ncia estat√≠stica nos gr√°ficos mencionado como ‚Äú10+‚Äù, contextualizando interpreta√ß√µes.
**Achados Adicionais**
- H√° mais de 1.000.000 fraturas/ano nos EUA; pelo menos 1/4 devido √† osteoporose.
- 15% das mulheres que fraturam morrem no primeiro ano e 75% perdem independ√™ncia ap√≥s a fratura.
- DNA FEN-AID com 42 biomarcadores epigen√©ticos do envelhecimento.

---

### Chunk 4/30
**Article:** Classification of Osteoporosis (2023)
**Journal:** Indian Journal of Orthopaedics
**Section:** abstract | **Similarity:** 0.605

The World Health Organization devised a BMD classification system utilizing T-scores for specific populations. T-score is defined as patient measured BMD value minus the reference BMD value divided by the reference standard deviation. T-scores apply to postmenopausal women and men aged 50 years and older. Conversely, Z-scores are preferred for premenopausal women, adults under 50, and children. The diagnostic approach emphasizes that bone mineral density measurement alone cannot diagnose osteoporosis in men under 50 years. The FRAX algorithm supplements BMD testing by incorporating clinical fracture risk predictors. Treatment is recommended when FRAX indicates a 10-year hip fracture probability of at least 3% or major osteoporotic fracture risk exceeding 20%.

---

### Chunk 5/30
**Article:** Prevention of Falls and Consequent Injuries in Elderly People (2012)
**Journal:** The Lancet
**Section:** abstract | **Similarity:** 0.587

Falls are the leading cause of fractures in older adults. This systematic review demonstrates that multifactorial fall prevention programs including exercise (particularly balance and strength training), home hazard modification, medication review, and vision correction reduce fall rates by 20-30%. For individuals with prior fractures, integrated fall prevention is essential alongside pharmacological osteoporosis treatment to minimize future fracture risk.

---

### Chunk 6/30
**Article:** Osteopenia (2025)
**Journal:** StatPearls [Internet]
**Section:** abstract | **Similarity:** 0.583

Osteopenia refers to reduced bone mineral density below normal values without fulfilling the diagnostic threshold for osteoporosis, measured via dual-energy x-ray absorptiometry (DXA). T-Score Classification: Normal within 1 SD, Osteopenia between -1.0 and -2.5, Osteoporosis less than -2.5. Clinical significance: approximately 48-56% of fragility fractures in postmenopausal women occur in individuals with osteopenia-level bone density. Management: Low-to-moderate risk receives nonpharmacologic management (exercise, calcium/vitamin D supplementation). High risk receives pharmacologic therapy when 10-year hip fracture probability reaches 3% or major osteoporotic fracture risk exceeds 20% via FRAX assessment. Prevalence: 43.3 million American adults over 50 have osteopenia, affecting approximately 50% of women and 30% of men.

---

### Chunk 7/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.580

Bonemineraldensity,CTXC-telopeptidecollagencrosslinksDuetal.BMCGeriatrics         (2021) 21:542 Page6of10

fourgroupsofpostmenopausalwomenwithdifferentbonemusclestatusesandanalyzedtherelationshipsofbiomarkerswiththeriskofosteoporosisandsarcopenia.Theresultsshowedthatelevatedoxytocinlevelswereas-sociatedwithareducedriskofosteoporosis,andele-vatedDHEAlevelswereassociatedwithareducedriskofsarcopenia.However,elevatedfollistatinlevelswereassociatedwithanincreasedriskofsarcopenia.ThecurrentstudyfoundthatDHEAandoxytocinweresig-nificantlylowerinpostmenopausalwomenwithahis-toryoffragilityfracturecomparedtowomenwithoutfracture(datanotshown).Therefore,serumDHEAandfollistatinmaybebiomarkersofsarcopenia,andserumoxytocinmaybeabiomarkerofosteoporosis.Severalstudiesshowedthatphysicalexerciseinflu-encedserumlevelsoffollistatinandDHEA[33‚Äì35].Ourresultsshowedthatpostmenopausalwomenwith-outosteoporosis/sarcopeniaperformedhigherexerciselevelsthanwomenwithosteoporosis/sarcopenia.Fortheseresults,weconsider

---

### Chunk 8/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.573

ifiedbyreviewofmedicalrecordsandimagingexaminations.Detailsofotherfractureswereobtainedbyself-report.AccordingtotheNationalOsteoporosisFoundation[15],fragilityfracturesarefracturesresultingfromanyfallfromastandingheightorless.Duetal.BMCGeriatrics         (2021) 21:542 Page2of10

AnthropometryWeightandheightweremeasuredwhenwearinglightclothingandwithoutshoes.Bodymassindex(BMI)wascalculatedbydividingweight(kg)bythesquareofheight(meter).Assessmentcriteriaofphysicalexerciseandmilkconsumptionweredefinedbasedonourprevi-ousresearchinShanghai[16]andonexpertconsensusofnutritionandexercisemanagement[17].1)Physicalexercisesweredefinedasrunning,walking,dancing,taichi,swimmingandballgames.Houseworkwasnotconsideredaformofphysicalexercise.Physicalexercisewasassessedinthreelevels:highlevel‚â•30min/dayoranaverage‚â•210min/week;lowlevel<30min/dayoranaverage<210min/week;andnoexercise,whichwasnotperforminganyofthedefinedexercisesforover1year.2)Milkconsumptionwasassessedbasedonthefollowingthreelevels:highl

---

### Chunk 9/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.571

rs,suchasserummyokines,sexhormones,andboneturnovermarkers.Associationsbetweenhistoryoffragilityfrac-ture,lifestyle,serumbiomarkersandosteoporosisandsarcopeniawereanalyzedusinglogisticregressionana-lysis.Osteoporosisandsarcopeniawerethedependentvariables,andhistoryoffragilityfractureandlifestyleandserumbiomarkersweretheindependentvariablesincludedintheregressionanalysis.Theresultsareshownasoddsratios(ORs)with95%confidenceinter-vals(CIs).StatisticalsignificancewassetatP<0.05.ResultsCharacteristicsofstudypopulationThegeneralcharacteristicsofthestudysubjectsarepre-sentedinTable1.Atotalof478postmenopausalwomenwereincludedinthisstudy.Themeanagewas66.77years,themeanageatmenopausewas50.22years,andthemeanBMIwas23.93kg/m2.Ninety-twosubjects(19.6%)sufferedfragilityfractures,and37ofthesesub-jectshadmorethanonefracture.Toanalyzethechangesinvariousindicatorswithaging,subjectsweredividedintothreegroups:age65,65‚â§age<75,and75‚â§age.Gripstrength,gaitspeed,serumlevelsofDHEA,oxytocin,BMDoffemoralneckand

---

### Chunk 10/30
**Article:** Terapia de Reposi√ß√£o Hormonal Feminina II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.566

osteoporose.
- 15% das mulheres que fraturam morrem no primeiro ano e 75% perdem independ√™ncia ap√≥s a fratura.
- DNA FEN-AID com 42 biomarcadores epigen√©ticos do envelhecimento.

---

## Teaching Note

Data e Hora: 2025-11-21 03:06:39
Local: [Inserir Local]
Aula: Terapia de Reposi√ß√£o Hormonal na Mulher
## Vis√£o Geral
A aula abordou a terapia de reposi√ß√£o hormonal (TRH) na mulher, come√ßando pela fisiologia do ciclo menstrual, esteroidog√™nese e a transi√ß√£o para a menopausa. Foram detalhados os sintomas climat√©ricos, com foco nos fogachos, e as consequ√™ncias a longo prazo da defici√™ncia hormonal, como osteoporose, risco cardiovascular e dem√™ncia. A sess√£o aprofundou a controv√©rsia em torno do estudo WHI, desmistificando seus resultados e destacando suas falhas metodol√≥gicas.

---

### Chunk 11/30
**Article:** Suplementa√ß√£o I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.563

ozinha.
- Resultados dependem de h√°bitos, exerc√≠cio com impacto, poss√≠vel reposi√ß√£o hormonal; em alguns casos, bisfosfonatos.
- Metabolismo da glicose: redu√ß√£o de glicemia p√≥s-prandial em homens jovens ap√≥s 1 semana; efeito discreto.
- C√¢ncer: defici√™ncia associada √† maior malignidade de c√¢ncer de pr√≥stata (via osteocalcina subcarboxilada); evid√™ncia de inibi√ß√£o em carcinoma hepatocelular.
- Longevidade: estudo de Rotterdam (2004) associa maior ingesta √† maior sobrevida (~7 anos), menor risco relativo de DCV (‚àí57%), menos calcifica√ß√£o de aorta (‚àí52%), menor mortalidade geral (‚àí26%).
- Fontes alimentares: natto (soja fermentada) √© a mais rica; tamb√©m f√≠gado de ganso e queijos (emmental, moles); aten√ß√£o a intoler√¢ncias e autoimunes.
- Aviso preliminar: considerar intera√ß√µes com anticoagulantes cumar√≠nicos; detalhamento em cardiologia futura.

---

### Chunk 12/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.562

I:Appendicularskeletalmassindex;AWGS:AsianWorkingGroupforSarcopenia;BDNF:Brain-derivedneurotrophicfactor;BMD:Bonemineraldensity;BMI:Bodymassindex;CI:Confidenceintervals;COPD:Chronicobstructivepulmonarydisease;CT:Computedtomography;CTX:C-telopeptidecollagencrosslinks;CV:Coefficientsofvariance;DHEA:Dehydroepiandrosterone;DXA:DualenergyX-rayabsorptiometry;E2:Estradiol;FSH:Folliclestimulatinghormone;LH:Luteinizinghormone;MRI:Magneticresonanceimaging;OR:Oddsratios;P1NP:N-terminalpropeptideoftype1collagen;PTH:Parathyroidhormone;SHBG:Sexhormone-bindingglobulin;SPPB:Shortphysicalperformancebattery;T2:Testosterone;TGF-Œ≤:Transforminggrowthfactor-beta;WHO:WorldHealthOrganization
Table4Correlationofhistoryoffragilefracture,lifestyleandserumbiomarkerswithosteoporosisorsarcopeniabyLogisticRegressionVariablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24 

---

### Chunk 13/30
**Article:** Gen√©tica e Epigen√©tica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.555

ualizados: definir faixas de FC, escolher modalidades (for√ßa/resist√™ncia) que promovam remodelamento muscular e biog√™nese mitocondrial; ajustar conforme nutri√ß√£o e status hormonal.
- [ ] 7. Desenvolver estrat√©gias alternativas de est√≠mulo √† biog√™nese mitocondrial para idosos ou pacientes com limita√ß√µes ao exerc√≠cio.
- [ ] 8. Solicitar 25(OH)D basal e repetir em ~2 meses; educar sobre metas 40‚Äì60 e tranquilizar quando n√≠veis estiverem entre 20‚Äì100, sem alarmismo com c√°lculo renal.
- [ ] 9. Iniciar vitamina D 2.000‚Äì10.000 UI/dia conforme n√≠vel basal; ajustar para manuten√ß√£o (2.000‚Äì5.000 UI; podendo 10.000‚Äì20.000 UI em alta demanda). Associar K2 (MK7 100‚Äì200 mcg) e ingerir com gordura.
- [ ] 10. Prescrever magn√©sio (glicina ou malato) em duas doses di√°rias, ajustando de 200‚Äì1.000 mg de magn√©sio elementar/dia conforme necessidade; considerar maior dose em inflama√ß√£o/estresse/hipertens√£o/transtornos ansiosos ou uso de altas doses de vitamina D.

---

### Chunk 14/30
**Article:** Suplementa√ß√£o I (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.553

alisar laudos e comparar pre√ßos de ativos com marcas como Essential para detectar discrep√¢ncias.
- [ ] 2. Planejar prescri√ß√£o de resveratrol considerando origem, forma e biodisponibilidade; priorizar poucos ativos de alta qualidade; avaliar ODF/transd√©rmico.
- [ ] 3. Integrar vitamina K2 (MK7/MK4) com vitamina D quando indicado; ajustar doses ao perfil do paciente e contraindica√ß√µes relativas, especialmente em cardiologia.
- [ ] 4. Estruturar protocolo para osteopenia/osteoporose: considerar reposi√ß√£o hormonal, exerc√≠cios com impacto (pular corda, corrida leve), muscula√ß√£o; base nutricional com D, K2, magn√©sio, c√°lcio e boro sem promessa de ‚Äúcura‚Äù isolada.
- [ ] 5. Educar pacientes sobre riscos do c√°lcio isolado na menopausa e propor alternativas baseadas em evid√™ncias.
- [ ] 6.

---

### Chunk 15/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.549

iablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24‚Äì2.51)0.69Milkconsumption(novs.high)1.39(0.57‚Äì3.34)0.466.32(1.04‚Äì38.29)0.045DHEA(ng/ml)0.75(0.61‚Äì1.05)0.060.73(0.51‚Äì0.96)0.032T20.89(0.63‚Äì1.24)0.620.78(0.44‚Äì2.22)0.72E20.67(0.33‚Äì2.65)0.580.90(0.46‚Äì3.12)0.65PTH(pg/ml)1.01(0.97‚Äì1.04)0.640.97(0.90‚Äì1.04)0.3625OHD(ng/ml)0.98(0.93‚Äì1.07)0.220.51(0.11‚Äì0.82)0.047CTX(pg/ml)1.02(0.98‚Äì1.05)0.171.02(0.92‚Äì1.12)0.78PINP(ng/ml)1.12(0.97‚Äì1.48)0.511.07(0.95‚Äì1.17)0.31Follistatin(ng/ml)1.08(0.56‚Äì2.09)0.171.66(1.19‚Äì3.57)0.022Myostatin(ng/ml)0.95(0.90‚Äì1.13)0.821.01(0.98‚Äì1.03)0.56BDNF(ng/ml)0.78(0.38‚Äì1.62)0.500.35(0.07‚Äì1.82)0.35Oxytocin(pg/ml)0.75(0.63‚Äì0.98)0.0190.88(0.57‚Äì1.01)0.14Multivariatelogisticanalysiswasperformedafteradjustingforage.DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagenc

---

### Chunk 16/30
**Article:** Aula J√©ssica Marques - Neurologia Funcional Integrativa 3 (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.549

agn√©sio, vitamina B12, folato (B9), vitamina D e ferritina/ferro; corrigir defici√™ncias conforme resultados.
- [ ] 3. Planejar introdu√ß√£o gradual de suplementa√ß√£o: iniciar uma formula√ß√£o, aguardar 2‚Äì3 dias, adicionar a segunda e, ap√≥s 2‚Äì3 dias, a terceira, monitorando efeitos colaterais.
- [ ] 4. Implementar ciclos de 60‚Äì90 dias entre plantas com mecanismos semelhantes, trocando para outra fam√≠lia ap√≥s cada ciclo para sensibilizar diferentes receptores.
- [ ] 5. Selecionar extratos padronizados com maior biodisponibilidade (ex.: Curcumin C3, Cureit, CurcuVail) e evid√™ncia cl√≠nica para compor formula√ß√µes.
- [ ] 6. Incorporar vias alternativas para idosos: avaliar uso de injet√°veis, transd√©rmicos, fotobiomodula√ß√£o, aromaterapia e tinturas conforme perfil e poder aquisitivo.
- [ ] 7. Estruturar rotina di√°ria do paciente com atividades √∫teis e significativas (cozinhar, organizar casa, acompanhar netos/filhos), promovendo pertencimento e utilidade.
- [ ] 8.

---

### Chunk 17/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.548

ancewassigniÔ¨Åcantlyimprovedin
thetraininggroup.Physicaltrainingloweredtherisk
offallto0.82(95%CI:0.70‚Äì0.97,P<0.05).Whenallinterventionswereimplemented,thereductioninriskwas0.67(95%CI:0.51‚Äì0.88,P<0.004).A2002meta-analysis(Robertsonetal.,2002)involved1016women65‚Äì97yearsofage.Muscletrainingcombinedwithbalancetrainingwasfound
toreducetheriskoffallto0.65(95%CI:0.57‚Äì0.75)andtheriskoffracturesto0.65(95%CI:0.53‚Äì0.81).Theprogramwasequallyeffectiveforpeoplewith
ourwithoutahistoryoffalls,butthe80+yearoldsgainedthemostfromit.ADanishstudy(Beyeretal.,2007)includedwomen70‚Äì90yearsofagewithahistoryofrecent40Pedersen&Saltin
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

fall.Thepatientswererandomizedtoacontrolgroup(n=33)andtoatraininggroup(n=32),whichunderwentatrainingprograminvolvingmod-
eratestrengthtrainingandbalanceexercisestwicea
weekfor6months.Thetrainingresultedinimprove-
mentofmusclestrength,extensi

---

### Chunk 18/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.545

a(n=8),ovariectomy(n=15),heartdisease(n=4),rheumatoidarthritis(n=8),chronicob-structivepulmonarydisease(COPD)(n=21),andthyroiddisease(n=13),thestudycohortincluded478women.Allparticipantswerehealthy,andnoneofthemsufferedfromdiseasesthataffectedbonemetabolism,suchashyperthyroidism,hyperparathyr-oidism,rheumatoidarthritis,chronicliverorrenaldisease,malnutrition,orCOPD,ortookanydrugsthataffectedbonemetabolism,e.g.,glucocorticoids,heparin,warfarin,thyroxine,sexhormones,bispho-sphonates,calcitonin,parathyroidhormoneanalog,orcalcitriol.TheInstitutionalReviewBoardofHuadongHospitalapprovedthestudyprotocol(2019K168).Alloftheparticipantssignedinformedconsentbeforethestudybegan.Wealsocollectedinformationonfracturesthatoc-curredaftermenopauseand1yearbeforestudyentry.Hipfracturesandspinefractureswereverifiedbyreviewofmedicalrecordsandimagingexaminations.Detailsofotherfractureswereobtainedbyself-report.AccordingtotheNationalOsteoporosisFoundation[15],fragilityfracturesarefracturesresultingfromanyfall

---

### Chunk 19/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.544

rethanonefracture.Toanalyzethechangesinvariousindicatorswithaging,subjectsweredividedintothreegroups:age65,65‚â§age<75,and75‚â§age.Gripstrength,gaitspeed,serumlevelsofDHEA,oxytocin,BMDoffemoralneckandtotalhip,andleanmassdecreasedsignificantlywithaging.Historyoffragil-ityfractureandserumlevelofT2increasedsignificantlywithage.Withincreasingage,theamountofphysicalexerciseandmilkconsumptiondecreasedsignificantly.Associationofserumbiomarkerswithbonemass,musclemassormusclestrengthadjustedforageStepwisemultivariatelinearregressionwasperformedtoassessthecorrelationbetweenbiomarkersandbonemass,musclemassandstrengthadjustedforage.TheresultsshowedthatDHEAwaspositivelyrelatedtohandgrip(Œ≤=0.403,p=0.041)andgaitspeed(Œ≤=0.58,p=0.004).Follistatin(Œ≤=‚àí0.28,p=0.01)wasnegativelyrelatedtoleanmass,andoxytocin(Œ≤=0.35,p=0.036)waspositivelyrelatedtoleanmass.Myostatin(Œ≤=0.92,p=0.021)waspositivelyrelatedtofatmass.Myostatin(Œ≤=‚àí0.31,p=0.032)andfollistatin(Œ≤=‚àí0.48,p=0.042)werenegativelyassociatedwithASM

---

### Chunk 20/30
**Article:** Fisiologia End√≥crina Feminina (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.544

o de risco individual antes de terapia hormonal: hist√≥rico pessoal/familiar de c√¢ncer de mama, trombose, risco cardiovascular; densidade mineral √≥ssea.
    - Diferenciar fogachos de outras causas de ‚Äúcalor‚Äù (carcinoide, mastocitose, f√°rmacos, ansiedade, etc.).
    - Considerar perfil lip√≠dico, marcadores inflamat√≥rios, sa√∫de √≥ssea (densitometria), sa√∫de urogenital e qualidade do sono.
    - Considerar interven√ß√µes graduais na transi√ß√£o menopausal (reposi√ß√£o de progesterona, estradiol, testosterona) conforme defici√™ncia, indica√ß√£o e riscos.
    - Educa√ß√£o da paciente para ades√£o terap√™utica informada e tomada de decis√£o compartilhada.
- Plano de Tratamento de Seguimento:
  - Mudan√ßas de estilo de vida:
    - Atividade f√≠sica regular, com √™nfase em treino de resist√™ncia (~250 minutos semanais) para sa√∫de √≥ssea, muscular e geral.
    - Higiene do sono (priorizar sono profundo entre ~22h‚Äì5h).

---

### Chunk 21/30
**Article:** Diretrizes brasileiras para o diagn√≥stico e tratamento da osteoporose em mulheres na p√≥s-menopausa (2017)
**Journal:** Revista Brasileira de Reumatologia
**Section:** abstract | **Similarity:** 0.542

Diretrizes da Sociedade Brasileira de Reumatologia para diagn√≥stico e tratamento da osteoporose. Define crit√©rios diagn√≥sticos por T-score, indica√ß√µes de tratamento farmacol√≥gico, metas terap√™uticas e monitoramento. Inclui recomenda√ß√µes espec√≠ficas para popula√ß√£o brasileira considerando fatores de risco locais.

---

### Chunk 22/30
**Article:** Vitamina D (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.537

ia (j√° realizada; dose n√£o especificada).
  - Suplementa√ß√£o: vitamina D (inicialmente 30.000 UI/dia), vitaminas B2 e B12, magn√©sio; poss√≠veis fitoter√°picos/antropos√≥ficos (n√£o especificados).
  - Inserir mais aqui.
- Pr√≥ximos Passos/Exames:
  - Monitorar 25(OH)D visando faixa de 40‚Äì100 ng/mL conforme recomenda√ß√µes da ABN, com individualiza√ß√£o por resposta cl√≠nica e laboratorial.
  - Monitorar PTH para manter pr√≥ximo ao limite inferior da normalidade, evitando hiperparatireoidismo relativo ou supress√£o excessiva.
  - Monitorar c√°lcio s√©rico total e ionizado, f√≥sforo, fun√ß√£o renal; avaliar hipercalci√∫ria periodicamente.
  - Revisar fun√ß√£o hep√°tica e medicamentos que interferem nas enzimas do citocromo P450 (corticoides, antiepil√©pticos).
  - Considerar avalia√ß√£o de magn√©sio (preferencialmente estado intracelular), riboflavina (B2), vitamina A, zinco, fun√ß√£o tireoidiana, perfil lip√≠dico e h√°bitos alimentares.

---

### Chunk 23/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.533

salwomen,52hadosteosarcopenia(10.9%),182hadosteoporosis(38.1%),51hadsarcopenia(10.6%),and193hadnosarcopeniaandnoosteoporosis(NonSP/NonOP)(40.4%).Thesubjectswithosteosarco-peniawereolder,performedlessphysicalexerciseandconsumedlessmilk.ThesesubjectsalsohadlowerlevelsofDHEA,oxytocinand25OHD,higherlevelsoffollista-tinandmorehistoryoffragilityfracturecomparedtothesubjectsinothergroups.DHEA(32.51¬±12.8and34.97¬±16.2vs.42.64¬±12.8and48.45¬±10.6,p=0.042)wassignificantlylower,andfollistatin(18.76¬±4.8and18.97¬±6.1vs.14.93¬±4.0and13.0¬±4.9,p=0.027)wassignificantlyhigherinthesarcopeniagroupthanthere-spectivelevelsinnonsarcopeniagroup.OxytocinwaslowerinosteoporosisandsarcopeniagroupscomparedtotheNonSP/NonOPgroup,anditwasthelowestinosteosarcopeniagroup.Alogisticregressionanalysis,ad-justedforage,demonstratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05‚Äì0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63‚Äì0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.frac

---

### Chunk 24/30
**Article:** Suplementa√ß√£o I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.533

√ß√£o de c√°lcio isolado na menopausa
- Estudos (2008) indicam que c√°lcio isolado n√£o resolve osteoporose e pode aumentar risco de IAM.
- Plausibilidade: d√©ficit hormonal na menopausa n√£o se corrige apenas com c√°lcio; √© necess√°rio ativar osteoblastos e mecanismos regulat√≥rios.
- Quando considerar c√°lcio: ingesta diet√©tica insuficiente, em combina√ß√£o com cofatores e estrat√©gia integrada.
### 12. Vitamina K2 (MK-7): papel, sinergias e evid√™ncias
- K2 (especialmente MK-7; tamb√©m MK-4) frequentemente associada √† vitamina D; n√£o √© ‚Äúessencial‚Äù para a D funcionar, mas s√£o sin√©rgicas e com fun√ß√µes distintas.
- Evid√™ncias: redu√ß√£o de perda de c√°lcio (~50% previsto, estudo de 1995); K2 isolada (mesmo com c√°lcio, D, magn√©sio, boro) n√£o resolve osteopenia/osteoporose sozinha.
- Resultados dependem de h√°bitos, exerc√≠cio com impacto, poss√≠vel reposi√ß√£o hormonal; em alguns casos, bisfosfonatos.

---

### Chunk 25/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.533

opause(y)49.69¬±3.150.51¬±3.549.43¬±2.350.15¬±3.60.76Historyoffracture(%)60.8%29.8%32.0%0<0.001Physicalexercise(%)No49.141.745.618.8<0.001Low31.429.333.532.80.023High19.529.020.948.4<0.001Milkconsumptionhigh(%)No41.635.738.730.3<0.001Low34.639.537.946.4<0.001High23.824.823.423.30.417DHEA(ng/ml)32.51¬±12.842.64¬±12.834.97¬±16.248.45¬±10.60.042PTH(pg/ml)44.5(29.5‚Äì57.2)40.5(29.3‚Äì55.8)34.5(28.3‚Äì42.9)45.4(32.9‚Äì58.5)0.09225OHD(ng/ml)21.61¬±8.121.2(15.4‚Äì28.5)23.97¬±9.524.3(19.1‚Äì27.7)20.54¬±7.318.3(13.9‚Äì22.7)25.87¬±12.226.4(19.3‚Äì35.3)0.024CTX(pg/ml)380.83¬±145.6425.89¬±183.19338.43¬±159.7372.60¬±210.30.364PINP(ng/ml)36.76¬±15.248.15¬±17.038.62¬±11.444.03¬±16.50.085Follistatin(ng/ml)18.76¬±4.814.93¬±4.018.97¬±6.113.0¬±4.90.027Myostatin(ng/ml)3.07¬±1.33.70¬±1.32.75¬±1.63.99¬±1.50.178BDNF(ng/ml)22.67¬±13.330.75¬±10.628.74¬±7.830.80¬±10.90.265Oxytocin(pg/ml)398.3(173.2‚Äì662.6)425.8(200.2‚Äì702.3)500.4(289.3‚Äì823.4)612.7(356.2‚Äì1276.5)0.022BMD(g/cm2)LumbarSpine0.703¬±0.150.695¬±0

---

### Chunk 26/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.530

.4%forCTXandbelow2.6and4.1%forP1NP,below2.7and6.5%forPTH,andbelow7.8and10.7%for25(OH)D.StatisticsSPSSv23(SPSSInc.,Chicago,IL,USA)wasusedtoanalyzethedata.KolmogorovSmirnovmethodwasusedtotestthenormaldistributionofdata.Continuousvari-ableswereexpressedasthemeanswithstandarddevi-ation,medianwithinterquartilerange(25‚Äì75%),andclassificationvariableswereexpressedaspercentages.DifferencesbetweengroupswereanalyzedusingANOVA,Kruskal-WallisHtestorPearson‚Äôschi-squaredDuetal.BMCGeriatrics         (2021) 21:542 Page3of10

testforcontinuousandcategoricalvariables,respect-ively.AftertheresidualwastestedbyExplore,multivari-atelinearregressionmodelswereconstructedtoanalyzethecorrelationbetweendependentvariables,suchasgripstrength,gaitspeed,leanmass,fatmass,ASMI,bonemass,andindependentcontinuouspredictors,suchasserummyokines,sexhormones,andboneturnovermarkers.Associationsbetweenhistoryoffragilityfrac-ture,lifestyle,serumbiomarkersandosteoporosisandsarcopeniawereanalyzedusinglogisticregressionana-lys

---

### Chunk 27/30
**Article:** Serum selenium and reduced mortality in middle-aged and older adults with prefrailty or frailty: the mediating role of inflammatory status (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.530

older adults and are associated with higher risks of falls, 
disability, hospitalization, and mortality (
1
). Moreover, previous 
studies in the US have shown that hospitalization costs for frail 
patients are more than twice those of non-frail patients (
2
). Frail 
patients undergoing the same surgical procedures incur 
significantly higher median surgery costs, with hospitalization 
expenses increasing by approximately 30% (
3
). As the global 
population continues to age, identifying modifiable factors 
that can reduce mortality risk and alleviate healthcare costs in 
these populations has become a priority in public health 
research (
4
).
Frailty and prefrailty in middle-aged and older adults result from 
cumulative physiological decline driven by biological aging, including 
chronic inammation, hormonal dysregulation, and mitochondrial 
dysfunction (
5
).

---

### Chunk 28/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.529

stratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05‚Äì0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63‚Äì0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.fracture)(OR0.45;95%CI0.01‚Äì0.86;p=0.015),milkconsumption(novs.high)(OR6.32;95%CI1.04‚Äì38.29;p=0.045),DHEA(OR0.73;95%CI0.51‚Äì0.96;p=0.032),follistatin(OR1.66;95%CI1.19‚Äì3.57;p=0.022)and25OHD(OR0.51;95%CI0.11‚Äì0.82;p=0.047)wereassociatedwithsarcopenia(Table4).DiscussionsUsingcohortsofcommunity-dwellingpostmenopausalwomeninShanghai,China,weexaminedtherelation-shipbetween13circulatingbiomarkers,includingDHEA,E2,T2,LH,FSH,myostatin,follistatin,oxytocin,BDNF,CTX,PINP,PTHand25OHD,andbonemass,musclemass,strengthandfunctiontoevaluatetheprac-ticalvalueofthesebiomarkersinclinicalpractice.FollistatinpositivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwi

---

### Chunk 29/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.529

otrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChinesepopulation.Wepreviouslypub-lishedarelevantarticle[16].ManystudiesshowedthatvitaminDwascloselyrelatedtomusclesandbones.Notably,ourresultsshowedthatexcludingtheinfluenceofvitaminD,oxytocinwasalsoassociatedwithosteo-porosis,andfollistatinandDHEAwereassociatedwithsarcopenia.Inourstudy,milkconsumption(<50mL/dayvs.‚â•250mL/day)(OR6.32;95%CI1.04‚Äì38.29;p=0.045)wasassociatedwithsarcopenia.Thereasonisthatmilkcontainsnutrients,especiallywheyprotein,thatmaybemyoprotective.Onetrialinvestigatedtheeffectofaddingmilkproteintothehabitualdietonskeletalmusclemass,strength,andphysicalperformanceinMexicanelderlyindividualswithoutsarcopenia.Theresultsshowedthatconsumptionmayreducetheriskofsarco-peniabyimprovingskeletalmusclemassduetotheadditionofnutrient-richdairyproteinstothehabitualdiet[36].However,curr

---

### Chunk 30/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIX (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.528

g/kg) e pr√°tica de exerc√≠cios de resist√™ncia para preservar massa muscular.
- [ ] 3. Todos os profissionais: Em doen√ßas cr√¥nicas sem causa org√¢nica clara ou com m√° resposta ao tratamento, investigar ativamente traumas de inf√¢ncia, estresse cr√¥nico e quest√µes emocionais n√£o resolvidas como poss√≠vel "causa primeira".
- [ ] 4. Terapeutas e psic√≥logos: Adotar "terapia de precis√£o", utilizando m√∫ltiplas ferramentas e combinando diferentes abordagens terap√™uticas para personalizar o tratamento e focar em resultados mensur√°veis, em vez de seguir uma √∫nica linha te√≥rica por longos per√≠odos.
- [ ] 5. Estudo pessoal: Pesquisar o conceito de "causa primeira" de Arist√≥teles para aprofundar a l√≥gica de buscar a origem dos problemas.
- [ ] 6. Estudo pessoal: Ler o livro de Bruce Lipton sobre a conex√£o entre mente e doen√ßas f√≠sicas.

---

## SOAP

> Data e Hora: 2025-11-17 16:33:53
> Paciente: 
> Diagn√≥stico:

## Hist√≥rico do Diagn√≥stico:
1. Hist√≥rico M√©dico: 
2.

---

